John H. Tucker

EVP, Chief Marketing Officer, Endo Pharmaceuticals Solutions Inc.

Companies

scPharmaceuticals (United States)Board member Nov 16, 2017 to now¹
scPharmaceuticals (United States)Chief executive officer Nov 16, 2017 to now¹
scPharmaceuticals (United States)President Nov 16, 2017 to now¹

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Oct 7, 2025Returned to company 318,502 shares of scPharmaceuticals (United States)²
Oct 7, 2025U 122,345 shares of scPharmaceuticals (United States)²
Feb 11, 2025Granted 200,000 shares of scPharmaceuticals (United States)³
Jan 3, 2025Shares withheld for tax 13,360 shares at $3.56 of scPharmaceuticals (United States)⁴
Jan 18, 2024Granted 113,560 shares of scPharmaceuticals (United States)⁵
Jan 2, 2024Shares withheld for tax 4,942 shares at $6.39 of scPharmaceuticals (United States)⁶
Jan 19, 2023Granted 66,665 shares at $6.14 of scPharmaceuticals (United States)⁷
Oct 7, 2022Shares withheld for tax 10,288 shares at $4.98 of scPharmaceuticals (United States)⁸
Oct 7, 2022Exercised options 42,250 shares of scPharmaceuticals (United States)⁸
Dec 3, 2021Bought 10,000 shares at $3.96 of scPharmaceuticals (United States)⁹

The numbers on this page point here. Each one links to the record it came from.